Diagnostic and predictive accuracy of anti-mullerian hormone for ovarian function after chemotherapy in premenopausal women with early breast cancer

PURPOSE: Accurate diagnosis and prediction of loss of ovarian function after chemotherapy for premenopausal women with early breast cancer (eBC) is important for future fertility and clinical decisions regarding the need for subsequent adjuvant ovarian suppression. We have investigated the value of...

Descripción completa

Detalles Bibliográficos
Autores principales: Anderson, Richard A., Kelsey, Tom W., Perdrix, Anne, Olympios, Nathalie, Duhamel, Orianne, Lambertini, Matteo, Clatot, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Preclinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927041/
https://www.ncbi.nlm.nih.gov/pubmed/34997365
http://dx.doi.org/10.1007/s10549-021-06508-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927041/
https://www.ncbi.nlm.nih.gov/pubmed/34997365
http://dx.doi.org/10.1007/s10549-021-06508-w

Ejemplares similares